Tunneling tool

Information

  • Patent Grant
  • D708324
  • Patent Number
    D708,324
  • Date Filed
    Wednesday, October 24, 2012
    12 years ago
  • Date Issued
    Tuesday, July 1, 2014
    10 years ago
  • US Classifications
    Field of Search
    • US
    • D24 133
    • D24 137
    • D24 138
    • D24 143
    • D24 144
    • D24 145
    • D24 146
    • D24 147
    • D24 148
    • D24 149
    • 606 001000
    • 606 080000
    • 606 085000
    • 606 130000
    • 606 139000
    • 606 148000
    • 606 167000
    • 606 169000
    • 606 170000
    • 606 171000
    • 606 174000
    • 606 175000
    • 606 176000
    • 606 180000
    • 606 205000
    • 606 206000
    • 604 022000
    • 604 027000
    • 600 104000
    • 600 153000
    • 600 154000
    • 600 564000
  • International Classifications
    • 2402
    • Term of Grant
      14Years
Abstract
Description


FIG. 1 is a perspective view of our tunneling tool in accordance with our new design;



FIG. 2 is a front view thereof;



FIG. 3 is a rear view thereof;



FIG. 4 is a right side view thereof;



FIG. 5 is a left side view thereof;



FIG. 6 is a top view thereof; and,



FIG. 7 is a bottom view thereof.


The broken lines in the figures are included for the purpose of illustrating portions of the tunneling tool that form no part of the claimed design.


Claims
  • The ornamental design for a tunneling tool, as shown and described.
US Referenced Citations (13)
Number Name Date Kind
D377524 Lipp Jan 1997 S
D460554 Park Jul 2002 S
D461246 Park Aug 2002 S
D492776 Nilsson Jul 2004 S
D492995 Rue et al. Jul 2004 S
D549825 O'Neill Aug 2007 S
D627882 Slowey et al. Nov 2010 S
7850639 Rue et al. Dec 2010 B2
D697208 Ehrlich Jan 2014 S
20130108680 Schwarz May 2013 A1
20130115264 Schwarz et al. May 2013 A1
20130144250 Schwarz et al. Jun 2013 A1
20130259934 Schwarz Oct 2013 A1
Non-Patent Literature Citations (2)
Entry
“Highlights of Supprelin Prescription Information”, Endo Pharmaceuticals (2012) PK000033 Rev. 07, 20 pgs.
“Highlights of Vantas Prescription Information”, Endo Pharmaceuticals (2012) PK000003 Rev. May 10, 2012, 22 pgs.